Harmony Biosciences Holdings Inc’s recent filing unveils that its CHIEF COMMERCIAL OFFICER Dierks Jeffrey unloaded Company’s shares for reported $1.1 million on Jan 16 ’25. In the deal valued at $37.41 per share,29,475 shares were sold. As a result of this transaction, Dierks Jeffrey now holds 0 shares worth roughly $0.0.
Then, Dierks Jeffrey sold 1,123 shares, generating $44,920 in total proceeds. Upon selling the shares at $40.00, the CHIEF COMMERCIAL OFFICER now owns 0 shares.
Before that, SANDIP KAPADIA bought 25,000 shares. Harmony Biosciences Holdings Inc shares valued at $976,250 were divested by the Officer at a price of $39.05 per share.
H.C. Wainwright initiated its Harmony Biosciences Holdings Inc [HRMY] rating to a Buy in a research note published on December 17, 2024; the price target was $75. UBS began covering HRMY with “Buy” recommendation on September 10, 2024. Citigroup started covering the stock on June 21, 2024. It rated HRMY as “a Buy”.
Price Performance Review of HRMY
On Tuesday, Harmony Biosciences Holdings Inc [NASDAQ:HRMY] saw its stock jump 3.61% to $40.46. Over the last five days, the stock has gained 11.00%. Harmony Biosciences Holdings Inc shares have risen nearly 17.58% since the year began. Nevertheless, the stocks have risen 26.75% over the past one year. While a 52-week high of $41.61 was reached on 01/21/25, a 52-week low of $28.14 was recorded on 01/10/25. SMA at 50 days reached $34.53, while 200 days put it at $33.40.
Levels Of Support And Resistance For HRMY Stock
The 24-hour chart illustrates a support level at 39.76, which if violated will result in even more drops to 39.07. On the upside, there is a resistance level at 41.04. A further resistance level may holdings at 41.63. The Relative Strength Index (RSI) on the 14-day chart is 75.22, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.35, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 6.05%. Stochastics %K at 92.82% indicates the stock is a selling.
How much short interest is there in Harmony Biosciences Holdings Inc?
A steep rise in short interest was recorded in Harmony Biosciences Holdings Inc stocks on 2024-12-31, growing by 0.26 million shares to a total of 5.71 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 5.45 million shares. There was a rise of 4.55%, which implies that there is a positive sentiment for the stock.
